相关实验视频
Updated: Jun 28, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
一本关于选择和使用新的性结肠炎治疗方法的实用指南
Tara Nagaraj1, John Shinn2, Kara De Felice2
1Department of Pharmacy.
新的性结肠炎治疗方法,如mirizikizumab,upadacitinib,ozanimod和etrasimod提供了新的机制. 乌帕达西提尼布显示出潜在的疗效但更高的风险,根据疾病严重程度和先前的治疗方法指导治疗决策.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一些新的生物药物和小分子,包括mirizikizumab,upadacitinib,ozanimod和etrasimod,现在已被批准用于中度至严重的性结肠炎.
- 缺乏对比临床试验,以指导这些新兴先进疗法的最佳定位和使用.
研究的目的:
- 审查新的性结肠炎治疗方法的疗效和安全性.
- 提出一个实用指南,用于在临床实践中定位这些新型药物.
主要方法:
- 对新的性结肠炎治疗方法的第三期临床试验数据的审查.
- 通过网络元分析进行间接证据综合.
- 专家意见整合用于治疗指导.
主要成果:
- 在生物经验丰富的患者中,ozanimod,etrasimod和mirizikizumab与upadacitinib相比显示了较低的诱导临床缓解率.
- 网络元分析表明,在生物素素和经验丰富的患者中,upadacitinib可能比其他先进疗法更有效.
- 乌帕达西替尼与最高的不良事件风险有关.
结论:
- 新型药物如mirizikizumab,upadacitinib,ozanimod和etrasimod扩大了性结肠炎的治疗选择.
- 对于轻度至中度的疾病,建议使用ozanimod或etrasimod作为一线药物.
- 对于中度至重度的疾病,米里齐祖马布被认为是第一线药物,而阿帕达西提尼布或米里齐祖马布是抗TNF耐药患者的考虑因素,平衡有效性和安全性.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...